Cancer discovery news

Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.

Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

melanoma-cells-547x410
Untapping the full potential of immunotherapies for more people with cancer

06/06/23 - Nafisa Sayani-Bromley

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential.
ICR Logo
ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment

04/06/23

A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.
High-resolution 3D structure of the SIN3B human protein complex.
Detailed structure of understudied cell division ‘nanomachine’ revealed

31/05/23

Researchers have revealed, at high-resolution, the structure of a human protein complex named SIN3B, which is a ‘nanomachine’ involved in regulating cell division – a fundamental process for life which, if it becomes uncontrolled, can lead to cancer.
pancreatic cancer cells
Major study reveals how pancreatic cancer changes its ‘diet’ to survive

17/05/23

Pancreatic cancer cells can change their ‘diet’ to keep growing, by switching from the sugar glucose to a back-up fuel called uridine, new research reveals.
A cancer sample pathology slide with computerised data points. Credit: ICR/Royal Marsden IPU.
England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably

11/05/23

England’s first centre of its kind is set to make significant improvements in cancer diagnosis and treatment – by combining pioneering digital imaging with artificial intelligence.
ICR Logo
Cell ‘nanobot’ breakthrough shines light on cause of aggressive cancers

10/05/23

Scientists have uncovered the inner workings of one of the most important and intricate ‘nanobots’ operating within our cells – using cutting-edge microscopy for visualising molecules almost at an atomic level. Their new study published in Nature has unveiled the critical step that switches on the spliceosome – a piece of cellular machinery that enables cells to build complex proteins.
Professor Kristian Helin, head and shoulders in frame, stood in front of the ICR's Centre for Cancer Drug Discovery
ICR’s Chief Executive elected as Foreign Member of the Royal Society

10/05/23

Professor Kristian Helin, a world-leading cancer researcher and Chief Executive of The Institute of Cancer Research, London, has been elected as a Foreign Member of the Royal Society in recognition of his outstanding contribution to cancer research.
Centre for Cancer Drug Discovery
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration

04/05/23

An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
lung-cancer-cells-dividing-547x411px
AI could help doctors diagnose lung cancer

02/05/23

Artificial intelligence (AI) could help doctors diagnose lung cancer earlier, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London.
b-cell-lymphoma 547x410
Scientists create potent ‘degrader’ of cancer-driving protein

26/04/23

Scientists at The Institute of Cancer Research, London, have created a compound that destroys a protein involved in driving cancers, including B-cell lymphoma.
Gerry Potter by the sea
ICR saddened by death of Gerry Potter

24/04/23

Former colleagues at The Institute of Cancer Research, London, have reacted with great sadness to news of the untimely death of Gerry Potter, at the age of 63.
A still from the video We Dance for Life, showing a top down view of people twirling umbrellas which are also a creative interpretation of cancer cells
Art and science collide in a creative collaboration between The London Cancer Hub and the Sutton community

19/04/23

An inspirational film featuring local dance groups, members of the Sutton community and scientists from The Institute of Cancer Research, London, premiered this month as part of a festival celebrating arts, science and culture in Sutton.